118 related articles for article (PubMed ID: 12817770)
1. Study design in osteoporosis: a European perspective.
Kanis JA; Alexandre JM; Bone HG; Abadie E; Brasseur D; Chassany O; Durrleman S; Lekkerkerker JF; Caulin F
J Bone Miner Res; 2003 Jun; 18(6):1133-8. PubMed ID: 12817770
[TBL] [Abstract][Full Text] [Related]
2. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
Rosenblatt M
J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
[TBL] [Abstract][Full Text] [Related]
3. Placebo controls in clinical trials of new therapies for osteoporosis.
Levine RJ
J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
[No Abstract] [Full Text] [Related]
4. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
[TBL] [Abstract][Full Text] [Related]
5. The Food and Drug Administration's Osteoporosis Guidance Document: past, present, and future.
Colman EG;
J Bone Miner Res; 2003 Jun; 18(6):1125-8. PubMed ID: 12817768
[TBL] [Abstract][Full Text] [Related]
6. Study designs in osteoporosis.
Temple RJ
J Bone Miner Res; 2003 Jun; 18(6):1129-32. PubMed ID: 12817769
[No Abstract] [Full Text] [Related]
7. Is it ethical to use placebos in osteoporosis trials?
Ragi-Eis S; Zerbini CA; Provenza JR; Griz LH; de Gregório LH; Russo LA; Silva NA; Borges JL; de Souza AC; Castro ML; Lewiecki EM
J Clin Densitom; 2006; 9(3):274-80. PubMed ID: 16931344
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis panel summary.
Capron A; Donaldson S; Raisz LG; Swift S
J Bone Miner Res; 2003 Jun; 18(6):1160-2. PubMed ID: 12817776
[No Abstract] [Full Text] [Related]
9. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
D'Agostino RB; Massaro JM; Sullivan LM
Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
[TBL] [Abstract][Full Text] [Related]
10. Placebo or active control trials of antipsychotic drugs?
Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
[TBL] [Abstract][Full Text] [Related]
11. The ethics of placebo-controlled trials.
Weijer C
J Bone Miner Res; 2003 Jun; 18(6):1150-3. PubMed ID: 12817774
[No Abstract] [Full Text] [Related]
12. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
13. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
14. Uncertain future of trials in osteoporosis.
Kanis JA; Oden A; Johnell O; Caulin F; Bone H; Alexandre JM; Abadie E; Lekkerkerker F
Osteoporos Int; 2002; 13(6):443-9. PubMed ID: 12107656
[TBL] [Abstract][Full Text] [Related]
15. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
16. Current issues in non-inferiority trials.
Fleming TR
Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
[TBL] [Abstract][Full Text] [Related]
17. Toward rapproachment in the placebo control debate. A calculated compromise of power.
Leon AC; Solomon DA
Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
[TBL] [Abstract][Full Text] [Related]
18. TACT method for non-inferiority testing in active controlled trials.
Wang SJ; Hung HM
Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
[TBL] [Abstract][Full Text] [Related]
19. When do the federal regulations allow placebo-controlled trials in children?
Miller FG; Wendler D; Wilfond B
J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
[No Abstract] [Full Text] [Related]
20. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
Wang SJ; Hung HM; Tsong Y; Cui L
Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
